Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9855533.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.
Medical subject headings
- Anticonvulsants
- Carbamazepine
- Epilepsy, Complex Partial